HCLTech presenta un primer trimestre sólido
14-07-2026 13:26 via prnewswire.com

HCLTech presenta un primer trimestre sólido

HCLTech presenta un primer trimestre sólido, impulsado por un récord de acuerdos por valor de 2.400 millones de dólares Los ingresos por IA avanzada crecen un 62,1% hasta alcanzar los 171 millones de dólares; la compañía planea invertir hasta 3.500 millones de rupias para establecer...
Read more »

PR Public relations news



Corgi Insurance Launches Golden, a Dedicated Sports and Entertainment Insurance Vertical Built for the $600 Billion Sports Industry
GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT$500 million
GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT$500 million
LONGi Makes S&P Global Energy Premier List of Tier 1 Cleantech Companies 2026
LONGi Makes S&P Global Energy Premier List of Tier 1 Cleantech Companies 2026
The University of Western Australia appoints SRM Technologies as Information Technology Partner for its India Branch Campuses
The University of Western Australia appoints SRM Technologies as Information Technology Partner for its India Branch Campuses
Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis
Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development
A Hitachi Group site selected as "Global Lighthouse Factory" by the World Economic Forum, marking the Group's second designation
A Hitachi Group site selected as "Global Lighthouse Factory" by the World Economic Forum, marking the Group's second designation
INVESTOR DEADLINE ALERT: PicS N.V. (PICS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
INVESTOR DEADLINE ALERT: PicS N.V. (PICS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
West Tennessee Bank Breaks Ground on Permanent Germantown Branch
West Tennessee Bank Breaks Ground on Permanent Germantown Branch
Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint
Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint
A THIRD FEDERAL RULING SAYS STIIIZY PRODUCTS DO NOT INFRINGE ON PAX PATENTS
A THIRD FEDERAL RULING SAYS STIIIZY PRODUCTS DO NOT INFRINGE ON PAX PATENTS
Monport Highlights the Growing Shift from Hobby Lasers to Production-Ready Desktop CO2 Laser Systems with the MEGAS
Catherine Hershey Schools for Early Learning Opens First Lancaster County Center
Catherine Hershey Schools for Early Learning Opens First Lancaster County Center
Space for Humanity's "Take Off in Zero-G" to Inspire the Next Generation of Global Space Communicators
Space for Humanity's "Take Off in Zero-G" to Inspire the Next Generation of Global Space Communicators
Desktop versie